Compare WHWK & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WHWK | ALIS |
|---|---|---|
| Founded | 2007 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.2M | 83.5M |
| IPO Year | N/A | 2025 |
| Metric | WHWK | ALIS |
|---|---|---|
| Price | $2.55 | $9.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 203.1K | 22.1K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,384,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $9.98 |
| 52 Week High | $3.81 | $10.21 |
| Indicator | WHWK | ALIS |
|---|---|---|
| Relative Strength Index (RSI) | 62.77 | N/A |
| Support Level | $2.10 | N/A |
| Resistance Level | $2.36 | N/A |
| Average True Range (ATR) | 0.16 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 100.00 | 0.00 |
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.